⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for microspheres

Every month we try and update this database with for microspheres cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the LiverNCT01098422
Colorectal Neop...
Liver Neoplasms
Yttrium-90 Radi...
18 Years - University of California, San Diego
Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck TumorsNCT02975739
Radioisotopes
Head and Neck N...
Holmium-166 (po...
18 Years - UMC Utrecht
Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck TumorsNCT02975739
Radioisotopes
Head and Neck N...
Holmium-166 (po...
18 Years - UMC Utrecht
Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant DiseaseNCT01864070
Liver Cancer
TheraSphere
Everolimus
Phone Call
18 Years - M.D. Anderson Cancer Center
A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the LiverNCT01098422
Colorectal Neop...
Liver Neoplasms
Yttrium-90 Radi...
18 Years - University of California, San Diego
Uterine Artery Embolization With Microspheres in Patients With Leiomyoma.NCT03535610
Uterine Leiomyo...
Uterine Emboliz...
18 Years - 50 YearsScitech Produtos Medicos Ltda
Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular CarcinomaNCT00910572
Hepatocellular ...
Liver Cancer
Yttrium-90 micr...
18 Years - 80 YearsFondazione IRCCS Istituto Nazionale dei Tumori, Milano
First In Human Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) DeviceNCT06192758
Prostate
Cancer
TheraSphere PCa
50 Years - Boston Scientific Corporation
First In Human Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) DeviceNCT06192758
Prostate
Cancer
TheraSphere PCa
50 Years - Boston Scientific Corporation
Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular CarcinomaNCT00910572
Hepatocellular ...
Liver Cancer
Yttrium-90 micr...
18 Years - 80 YearsFondazione IRCCS Istituto Nazionale dei Tumori, Milano
DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCCNCT06190665
Hepatocellular ...
DEB-TACE with v...
DEB-TACE with P...
18 Years - 80 YearsZhongda Hospital
Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular CarcinomaNCT00910572
Hepatocellular ...
Liver Cancer
Yttrium-90 micr...
18 Years - 80 YearsFondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant DiseaseNCT01864070
Liver Cancer
TheraSphere
Everolimus
Phone Call
18 Years - M.D. Anderson Cancer Center
Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular CarcinomaNCT00910572
Hepatocellular ...
Liver Cancer
Yttrium-90 micr...
18 Years - 80 YearsFondazione IRCCS Istituto Nazionale dei Tumori, Milano
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: